(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435UAA97

IBDS: Corporate Bonds, Investment Grade, Fixed Income, Target Maturity, 2027

The iShares iBonds Dec2027 Term Corporate ETF is a targeted maturity ETF that focuses on investment-grade corporate bonds with a maturity date in December 2027. This fund is designed to provide investors with a predictable income stream and relatively lower volatility by investing in high-quality, U.S. dollar-denominated corporate bonds.

By tracking a specific index composed of investment-grade corporate bonds maturing in 2027, the fund aims to deliver a stable return profile. The underlying bonds are selected based on their creditworthiness, liquidity, and maturity, ensuring that investors are exposed to a diversified portfolio of high-grade corporate debt.

Given the current market conditions and the funds characteristics, we can analyze the potential future performance. With a current price of $24.15 and a 20-day SMA of $24.09, the fund is showing a slight upward trend. The 50-day and 200-day SMAs at $24.01 and $23.68, respectively, indicate a longer-term uptrend. The Average True Range (ATR) of 0.05 (0.22%) suggests relatively low volatility.

Using the available technical and fundamental data, a forecast can be made. With the funds AUM at $3.053 billion, it has sufficient liquidity to track its underlying index effectively. Considering the current yield curve and the funds focus on investment-grade corporate bonds, we can expect the fund to continue its stable performance. As the maturity date approaches, the funds duration will decrease, potentially leading to lower volatility and a more predictable return. Based on the current trend and assuming no significant changes in market conditions, a potential price target for IBDS could be around $24.30-$24.50 in the short term, representing a 0.6%-1.4% increase from the current price.

Additional Sources for IBDS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IBDS ETF Overview

Market Cap in USD 3,102m
Category Target Maturity
TER 0.10%
IPO / Inception 2017-09-12

IBDS ETF Ratings

Growth Rating 23.5
Fundamental -
Dividend Rating 71.6
Rel. Strength -6.34
Analysts -
Fair Price Momentum 23.80 USD
Fair Price DCF -

IBDS Dividends

Dividend Yield 12m 4.44%
Yield on Cost 5y 4.65%
Annual Growth 5y 7.44%
Payout Consistency 95.1%
Payout Ratio %

IBDS Growth Ratios

Growth Correlation 3m 92.8%
Growth Correlation 12m 93.8%
Growth Correlation 5y 2.3%
CAGR 5y 1.21%
CAGR/Max DD 5y 0.08
Sharpe Ratio 12m 1.24
Alpha 2.57
Beta -0.004
Volatility 1.98%
Current Volume 607.8k
Average Volume 20d 628.9k
What is the price of IBDS shares?
As of June 29, 2025, the stock is trading at USD 24.25 with a total of 607,787 shares traded.
Over the past week, the price has changed by +0.33%, over one month by +0.78%, over three months by +1.57% and over the past year by +6.73%.
Is iShares iBonds Dec 2027 a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares iBonds Dec 2027 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.54 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDS is around 23.80 USD . This means that IBDS is currently overvalued and has a potential downside of -1.86%.
Is IBDS a buy, sell or hold?
iShares iBonds Dec 2027 has no consensus analysts rating.
What are the forecasts for IBDS share price target?
According to our own proprietary Forecast Model, IBDS iShares iBonds Dec 2027 will be worth about 25.7 in June 2026. The stock is currently trading at 24.25. This means that the stock has a potential upside of +5.98%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.7 6%